Date Field | Doc. No. | Description (Pages) |
---|
Nov 16, 2023 | 18 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG, Corporate Parent Sandoz Group AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 11/16/2023) (2) |
Jul 17, 2023 | 17 | MOTION for Pro Hac Vice Appearance of Attorney Judy He of Crowell & Moring LLP - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 07/17/2023) (3) |
Dec 22, 2022 | 16 | STIPULATION and [Proposed] Order to Consolidate and Extend Time by Array BioPharma Inc.. (Dellinger, Megan) (Entered: 12/22/2022) (2) |
Nov 23, 2022 | 15 | ANSWER to 12 Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Array BioPharma Inc..(Dellinger, Megan) (Entered: 11/23/2022) (16) |
Nov 4, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli and David McMullen - filed by Array BioPharma Inc., Array BioPharma, Inc.. (Dellinger, Megan) (Entered: 11/04/2022) (6) |
Nov 2, 2022 | 12 | ANSWER to 1 Complaint with Jury Demand , COUNTERCLAIM against Array BioPharma Inc. by Sandoz Inc..(Gattuso, Dominick) (Entered: 11/02/2022) (30) |
Nov 2, 2022 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 11/02/2022) (2) |
Oct 28, 2022 | 11 | ORDER re 8 Unopposed Motion to Place Complaint Under Seal filed by Sandoz Inc. Signed by Judge Gregory B. Williams on 10/28/22. (ntl) (Entered: 10/28/2022) (1) |
Oct 27, 2022 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and Alexis S. White of Crowell & Moring LLP - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 10/27/2022) (5) |
Oct 27, 2022 | 10 | RESPONSE to Motion re 8 MOTION to Seal Document: 1 Complaint Unopposed Motion to Place Complaint Under Seal filed by Array BioPharma Inc.. (Blumenfeld, Jack) (Entered: 10/27/2022) (3) |
Oct 26, 2022 | 8 | MOTION to Seal Document: 1 Complaint Unopposed Motion to Place Complaint Under Seal - filed by Sandoz Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1)(Gattuso, Dominick) (Entered: 10/26/2022) (Main Document) (6) |
Oct 26, 2022 | 8 | MOTION to Seal Document: 1 Complaint Unopposed Motion to Place Complaint Under Seal - filed by Sandoz Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1)(Gattuso, Dominick) (Entered: 10/26/2022) (Text of Proposed Order) (1) |
Oct 26, 2022 | 8 | MOTION to Seal Document: 1 Complaint Unopposed Motion to Place Complaint Under Seal - filed by Sandoz Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1)(Gattuso, Dominick) (Entered: 10/26/2022) (Exhibit 1) (19) |
Oct 12, 2022 | 7 | SUMMONS Returned Executed by Array BioPharma Inc..Sandoz Inc. served on 10/12/2022, answer due 11/2/2022. (Blumenfeld, Jack) (Entered: 10/12/2022) (2) |
Oct 6, 2022 | 1 | Complaint* (1) |
Oct 6, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 10/06/2022) (3) |
Oct 6, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/24/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/27/2025. (vfm) (Entered: 10/06/2022) (1) |
Oct 6, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,314,464 B2 ;9,850,229 B2 ;10,005,761 B2 ;9,562,016 B2 ;9,598,376 B2 ;9,980,944 B2. (vfm) (Entered: 10/06/2022) (2) |
Oct 6, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Array BioPharma Inc. filed by Array BioPharma Inc.. (vfm) (Entered: 10/06/2022) (1) |
Oct 6, 2022 | 6 | Summons Issued as to Sandoz Inc. on 10/6/2022. (vfm) (Entered: 10/06/2022) (2) |